Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesna for cysteine lowering in obesity
NCT04449536Phase 1Completed
- Sponsor
- University of Oslo
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesna in obesity, sponsored by University of Oslo. Primary endpoint: Change in plasma total cysteine concentrations at 3 days. Started Nov 2020; status: completed.
02
Drugs
mesna
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04449536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449536.